- Home
- EQ vs STHO Comparison
EQ vs STHO Comparison
Compare EQ & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQ | STHO |
|---|---|---|
| Founded | 2017 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.1M | 120.0M |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EQ | STHO |
|---|---|---|
| Price | $1.67 | $8.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 515.0K | 15.4K |
| Earning Date | 05-25-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.73 |
| EPS | N/A | ★ 2.58 |
| Revenue | $41,095,000.00 | ★ $110,143,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.76 | $7.08 |
| 52 Week High | $3.54 | $9.94 |
Technical Indicators
Market Signals| Indicator | EQ | STHO |
|---|---|---|
| Relative Strength Index (RSI) | 32.24 | 20.82 |
| Support Level | $1.05 | $8.25 |
| Resistance Level | $1.71 | $9.16 |
| Average True Range (ATR) | 0.18 | 0.24 |
| MACD | -0.04 | -0.12 |
| Stochastic Oscillator | 1.44 | 0.30 |
Price Performance
Historical ComparisonAbout EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.